Felix Baker, Director at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 123,489 shares at $126.25 ($15.6M) on 2019-05-28, disclosed to the SEC on 2019-05-30.
Open-market sale of $15.6M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.05 | 2,749 | $344K | 2.2% |
| 2 | $125.05 | 22,886 | $2.9M | 18.3% |
| 3 | $126.25 | 1,867 | $236K | 1.5% |
| 4 | $126.25 | 15,541 | $2.0M | 12.6% |
| 5 | $127.06 | 8,627 | $1.1M | 7.0% |
| 6 | $127.06 | 71,819 |
| $9.1M |
| 58.4% |
| Total | $126.53 avg | 123,489 | $15.6M | 100% |
| Filing → |
| MDGL | BUY | 2025-08-20 | $48.5M | — | Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |